Skip to main navigation Skip to search Skip to main content

Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys

  • on behalf of the World Health Organization's World Mental Health Surveys collaborators
  • The University of Queensland
  • The Park Centre for Mental Health
  • National Drug and Alcohol Research Centre
  • National Institute on Drug Abuse (NIDA)
  • Harvard Medical School
  • Al-Qadisiya University
  • Institut Hospital del Mar d’Investigacions Mediques
  • Pompeu Fabra University
  • Katholieke Universiteit Leuven
  • Universidade Nova de Lisboa
  • Anxiety Disorders Research Center
  • Istituto di Ricovero e Cura a Carattere Scientifico
  • National School of Public Health, Management and Professional Development
  • University College Hospital, Ibadan
  • Universitat de Barcelona
  • National Center of Public Health and Analyses
  • University of Balamand
  • St George Hospital University Medical Center
  • Institute for Development, Research, Advocacy and Applied Care, Beirut
  • Research
  • The Chinese University of Hong Kong
  • University Paris Diderot and Paris Descartes
  • Ministry of Health
  • Aarhus University
  • University of Michigan, Ann Arbor
  • IMIB-Arrixaca
  • Colegio Mayor de Cundinamarca University
  • University of Otago
  • National Center of Neurology and Psychiatry
  • Netherlands Institute of Mental Health and Addiction
  • CES University
  • Federal University of Espírito Santo
  • World Health Organization

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Aims: To examine cross-national patterns of 12-month substance use disorder (SUD) treatment and minimally adequate treatment (MAT), and associations with mental disorder comorbidity. Design: Cross-sectional, representative household surveys. Setting: Twenty-seven surveys from 25 countries of the WHO World Mental Health Survey Initiative. Participants: A total of 2446 people with past-year DSM-IV SUD diagnoses (alcohol or illicit drug abuse and dependence). Measurements: Outcomes were SUD treatment, defined as having either received professional treatment or attended a self-help group for substance-related problems in the past 12 months, and MAT, defined as having either four or more SUD treatment visits to a health-care professional, six or more visits to a non-health-care professional or being in ongoing treatment at the time of interview. Covariates were mental disorder comorbidity and several socio-economic characteristics. Pooled estimates reflect country sample sizes rather than population sizes. Findings: Of respondents with past-year SUD, 11.0% [standard error (SE) = 0.8] received past 12-month SUD treatment. SUD treatment was more common among people with comorbid mental disorders than with pure SUDs (18.1%, SE = 1.6 versus 6.8%, SE = 0.7), as was MAT (84.0%, SE = 2.5 versus 68.3%, SE = 3.8) and treatment by health-care professionals (88.9%, SE = 1.9 versus 78.8%, SE = 3.0) among treated SUD cases. Adjusting for socio-economic characteristics, mental disorder comorbidity doubled the odds of SUD treatment [odds ratio (OR) = 2.34; 95% confidence interval (CI) = 1.71–3.20], MAT among SUD cases (OR = 2.75; 95% CI = 1.90–3.97) and MAT among treated cases (OR = 2.48; 95% CI = 1.23–5.02). Patterns were similar within country income groups, although the proportions receiving SUD treatment and MAT were higher in high- than low-/middle-income countries. Conclusions: Few people with past-year substance use disorders receive adequate 12-month substance use disorder treatment, even when comorbid with a mental disorder. This is largely due to the low proportion of people receiving any substance use disorder treatment, as the proportion of patients whose treatment is at least minimally adequate is high.

Original languageEnglish
Pages (from-to)1446-1459
Number of pages14
JournalAddiction
Volume114
Issue number8
DOIs
StatePublished - Aug 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Comorbidity
  • World Mental Health Surveys
  • mental disorders
  • minimally adequate treatment
  • substance use disorders
  • treatment

Fingerprint

Dive into the research topics of 'Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys'. Together they form a unique fingerprint.

Cite this